Cargando…
Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming
BACKGROUND: Mesenchymal stem cells (MSCs) are one of the most promising candidates for the treatment of major neurological disorders. Desirable therapeutic properties of MSCs include reparative and regenerative potential but, despite their proven safety, the efficacy of MSCs remains controversial. T...
Autores principales: | Redondo-Castro, Elena, Cunningham, Catriona J., Miller, Jonjo, Brown, Helena, Allan, Stuart M., Pinteaux, Emmanuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773162/ https://www.ncbi.nlm.nih.gov/pubmed/29343288 http://dx.doi.org/10.1186/s13287-017-0753-5 |
Ejemplares similares
-
Interleukin-1 primes human mesenchymal stem cells towards an anti-inflammatory and pro-trophic phenotype in vitro
por: Redondo-Castro, Elena, et al.
Publicado: (2017) -
Systemic conditioned medium treatment from interleukin-1 primed mesenchymal stem cells promotes recovery after stroke
por: Cunningham, Catriona J., et al.
Publicado: (2020) -
The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke
por: Cunningham, Catriona J, et al.
Publicado: (2018) -
Therapeutic potential of extracellular vesicles in preclinical stroke models: a systematic review and meta-analysis
por: Thomas, Josephine M, et al.
Publicado: (2020) -
Interleukins Profiling in Umbilical Cord Mesenchymal Stem Cell-Derived Secretome
por: Chouw, Angliana, et al.
Publicado: (2022)